Breaking News, Collaborations & Alliances

Bespak Enters Collaborations Focused on Advancing the Transition to Low GMP Propellants in pMDIs

Joins forces with The Medicines Evaluation Unit (MEU) and H&T Presspart.

Author Image

By: Charlie Sternberg

Associate Editor

Bespak, a contract development and manufacturing organization (CDMO) focused on orally inhaled and nasal drug-device combination products, has announced new collaborations with The Medicines Evaluation Unit (MEU) and H&T Presspart.   Both partnerships are aimed at accelerating the industry’s transition from existing pressurized Metered Dose Inhaler (pMDI) formulations to more climate-friendly alternatives utilizing low global warming potential (GWP) propellants. Collaboration with The ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters